The content is available as a PDF (1.6 MB).
Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report
Chun-yang Xu
Sheng-dong Lu
Xun Ye
Meng-yi Cao
Gui-dong Xu
Qiang Yu
Jin-xian Qian
Gang Zeng
Chun-yang Xu, Sheng-dong Lu. These authors contributed equally to this work
Correspondence: Jin-xian Qian, M.D, Department of Respiratory and Critical Care Medicine, Suzhou Municipal Hospital of Nanjing Medical University, No 242 Guangji Road, Suzhou 215000, Jiangsu, China. E-mai: szicu@sina.com
Co-Correspondence: Gang Zeng, M.D, Department of Respiratory and Critical Care Medicine, Suzhou Municipal Hospital of Nanjing Medical University, No 242 Guangji Road, Suzhou 215000, Jiangsu, China. E-mai: szhzg1206@163.com
Received 2020 Apr 20; Accepted 2020 Apr 21.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.